Compare PYPD & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYPD | BIOX |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | Israel | Argentina |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.4M | 77.4M |
| IPO Year | 2020 | N/A |
| Metric | PYPD | BIOX |
|---|---|---|
| Price | $4.63 | $1.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $12.00 | $4.33 |
| AVG Volume (30 Days) | 94.5K | ★ 495.5K |
| Earning Date | 02-11-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $318,158,904.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.12 |
| 52 Week High | $5.05 | $7.17 |
| Indicator | PYPD | BIOX |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 35.97 |
| Support Level | $4.51 | $1.17 |
| Resistance Level | $4.92 | $1.30 |
| Average True Range (ATR) | 0.30 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 58.04 | 6.15 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.